Skip to main content

Advertisement

Table 6 Regression analysis models of risk factors associated with infection-related death among 76 patients infected by CRE, excluding urinary tract infections, between March 2011 and December 2012

From: A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome

Variable Total Survivors Deaths OR (95 % CI) P
First model
 60 y or over 32 (42.1 %) 15 (34.0 %) 17 (53.1 %) 3.10 (0.81–11.87) 0.09
 Shock 47 (61.8 %) 18 (38.3 %) 29 (61.7 %) 5.84 (1.30–26.12) 0.02
 Dialysis 35 (46.0 %) 29 (61.7 %) 29 (61.7 %) 4.76 (1.22–18.55) 0.02
 Sensitive ATM less than 12 h 25 (32.9 %) 11 (44.0 %) 14 (56.0 %) 1.51 (0.45–5.01) 0.49
 Pneumonia 52 (68.4 %) 25 (48.0 %) 27 (56.0 %) 1.55 (0.40–6.03) 0.52
 Monotherapy 1 (1.3 %) 1 (100 %) 0 (0 %) 0.0001 (0.00–0.00) 0.97
 More than two comorbidities     1.50 (0.44–5.08) 0.50
  1. CRE carbapenem-resistant infection, OR odds ratio, CI confidence interval, ATM antimicrobial